| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.29 | 5e-13 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.34 | 2e-09 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-09 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.28 | 6e-09 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.32 | 2e-08 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.23 | 2e-08 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-08 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.2 | 4e-07 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.19 | 9e-07 |